Get our Free Patent Expiration, Litigation, and Drug Price Updates

Serving hundreds of leading biopharmaceutical companies globally:

Medtronic
Cantor Fitzgerald
Daiichi Sankyo
Baxter
Teva
Covington

Generated: June 17, 2019

DrugPatentWatch Database Preview

COSOPT Drug Profile

« Back to Dashboard

Drug patent expirations by year for COSOPT
Synonyms for COSOPT
(4S,6S)-4-(Ethylamino)-5,6-dihydro-6-methyl-4H-thieno(2,3-b)thiopyran-2-sulfonamide 7,7-dioxide, monohydrochloride
(4S,6S)-4-(ethylamino)-6-methyl-5,6-dihydro-4H-thieno[2,3-b]thiopyran-2-sulfonamide 7,7-dioxide hydrochloride
(4S,6S)-4-(ethylamino)-6-methyl-7,7-dioxo-5,6-dihydro-4H-thieno[2,3-b]thiopyran-2-sulfonamide hydrochloride
(4S,6S)-4-(ethylamino)-6-methyl-7,7-dioxo-5,6-dihydro-4H-thieno[2,3-b]thiopyran-2-sulfonamide;hydrochloride
130693-82-2
279D961
4H-Thieno(2,3-b)thiopyran-2-sulfonamide, 4-(ethylamino)-5,6-dihydro-6-methyl-, 7,7-dioxide, monohydrochloride, (4S-trans)-
4H-Thieno(2,3-b)thiopyran-2-sulfonamide, 5,6-dihydro-4-(ethylamino)-6-methyl-, 7,7-dioxide, monohydrochloride, (4S,6S)-
ABP001060
AC-5244
AC1OCF25
AKOS005146235
AKOS015895951
API0007146
BC208520
C10H16N2O4S3.HCl
CAS-130693-82-2
CC-27373
CCG-221116
CHEBI:4703
CHEMBL1201162
CS-1858
CTK8E7974
D00653
D4189
Dorzolamide (hydrochloride)
Dorzolamide for system suitability, European Pharmacopoeia (EP) Reference Standard
Dorzolamide HCl
Dorzolamide HCl salt
DORZOLAMIDE HYDROCHLORIDE
Dorzolamide hydrochloride (JP17/USP)
Dorzolamide hydrochloride [USAN:USP]
Dorzolamide hydrochloride, European Pharmacopoeia (EP) Reference Standard
Dorzolamide hydrochloride, United States Pharmacopeia (USP) Reference Standard
Dorzolamide impurity A
Dorzolomide hydrochloride
DSSTox_CID_25530
DSSTox_GSID_45530
DSSTox_RID_80933
DTXSID1045530
FT-0082547
FT-0631133
HMS1571O14
HY-B0109A
I06-1271
J10249
K-4065
KB-50425
KS-00000XJI
KS-1348
L 671152
L-671,152
L-671152
MK 0507
MK-0507
MK-507
MLS002154162
MolPort-005-935-141
NCGC00016977-01
NCGC00179244-03
OSRUSFPMRGDLAG-QMGYSKNISA-N
QZO5366EW7
RTC-070963
s1375
SC-18010
SCHEMBL41152
SMR001233461
SR-05000001449
SR-05000001449-3
TC-070963
Tox21_110720
Tox21_110720_1
Trusopt
Trusopt (TN)
UNII-QZO5366EW7

US Patents and Regulatory Information for COSOPT

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Oak Pharms Inc COSOPT dorzolamide hydrochloride; timolol maleate SOLUTION/DROPS;OPHTHALMIC 020869-001 Apr 7, 1998 AT RX Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Oak Pharms Inc COSOPT PF dorzolamide hydrochloride; timolol maleate SOLUTION/DROPS;OPHTHALMIC 202667-001 Feb 1, 2012 AT RX Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

Subscribe to access the full database, or try a Free Trial

Expired US Patents for COSOPT

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Oak Pharms Inc COSOPT dorzolamide hydrochloride; timolol maleate SOLUTION/DROPS;OPHTHALMIC 020869-001 Apr 7, 1998 ➤ Sign Up ➤ Sign Up
Oak Pharms Inc COSOPT dorzolamide hydrochloride; timolol maleate SOLUTION/DROPS;OPHTHALMIC 020869-001 Apr 7, 1998 ➤ Sign Up ➤ Sign Up
Oak Pharms Inc COSOPT dorzolamide hydrochloride; timolol maleate SOLUTION/DROPS;OPHTHALMIC 020869-001 Apr 7, 1998 ➤ Sign Up ➤ Sign Up
Oak Pharms Inc COSOPT dorzolamide hydrochloride; timolol maleate SOLUTION/DROPS;OPHTHALMIC 020869-001 Apr 7, 1998 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

Subscribe to access the full database, or try a Free Trial

Paragraph IV (Patent) Challenges for COSOPT
Drugname Dosage Strength RLD Date
➤ Subscribe Ophthalmic Solution 2%/0.5% ➤ Subscribe ➤ Sign Up

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Army
Chubb
Daiichi Sankyo
Farmers Insurance
Merck
Cipla

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.